COMMUNIQUÉS West-GlobeNewswire

Zosano Pharma Announces Upcoming Oral and Poster Presentations at the Congress of the International Headache Society
23/08/2019
Oral presentation of the safety and efficacy of Qtrypta TM in a long-term safety study for the acute treatment of migraine. Poster on the results of patients’ freedom from pain and most bothersome symptom when taking [...]
Bravo Recognized as a 2019 NorthCoast 99 Award Winner
23/08/2019
CLEVELAND, Aug. 23, 2019 (GLOBE NEWSWIRE) -- Bravo is honored to be recognized by ERC as a 2019 NorthCoast 99 Award recipient. This is the first year the organization has been named among the 99 great workplaces for top [...]
Seelos Therapeutics Announces Pricing of $6.7 Million Registered Direct Offering
23/08/2019
NEW YORK, Aug. 23, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announced today that it has entered into a securities purchase agreement with certain [...]
Rafarma to Commence Production in Thailand; Predicted to Be The Region’s “Cannabis Capital”
23/08/2019
Ljubljana, Slovenia, Aug. 23, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is positioning to expand its operations in the “next big thing” in cannabis production—Thailand. Rafarma is [...]
The Largest Private Plastic and Reconstructive Surgery Practice in the U.S. Welcomes Dr. Irena Karanetz as the 20th Physician at Long Island Plastic Surgical Group
23/08/2019
Garden City, NY, Aug. 23, 2019 (GLOBE NEWSWIRE) -- Long Island Plastic Surgical Group (LIPSG) is pleased to announce the addition of Dr. Irena Karanetz to the nation’s largest team of highly skilled plastic surgeons. Dr [...]
Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector
23/08/2019
NEW YORK, Aug. 23, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of an audio press release broadcast titled, “Record Revenues, Milestone Achievements Indicate [...]
HST Global, Inc. Announces Entering into an Agreement to Purchase a Financial Services Revenue Sharing Contract.
23/08/2019
Hampton, VA , Aug. 23, 2019 (GLOBE NEWSWIRE) -- HST Global, Inc. (OTC:HSTC), “HSTC” or “the Company,” announced that it has entered into an Asset Purchase Agreement with Orbital Group, Inc., a Wyoming corporation to [...]
Intercept to Present at Upcoming Investor Conferences in September
23/08/2019
NEW YORK, Aug. 23, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
BeyondSpring’s Plinabulin Demonstrates Superior Quality of Life Over Pegfilgrastim in a Head-to-Head Comparison Trial for the Prevention of Neutropenia
23/08/2019
Data to be Presented at IASLC 2019 World Conference on Lung Cancer NEW YORK, Aug. 23, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of [...]
BioSyent Releases Q2 and H1 2019 Results
23/08/2019
MISSISSAUGA, Ontario, Aug. 23, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30, 2019. Key highlights [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
23/08/2019
Company announcement – No. 26 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, August 23, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 [...]
Ziopharm Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/08/2019
BOSTON, Aug. 23, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP) today reported that the Company granted a new employee an option to purchase an aggregate of 65,000 shares [...]
Hemispherx Biopharma, Inc. Changes Name to AIM ImmunoTech Inc. Reflecting Ampligen’s® Immuno Modulation Progress in Ongoing Oncology Clinical Trials and ME/CFS
23/08/2019
Announces new ticker symbol ‘AIM’ effective September 3, 2019 OCALA, Fla., Aug. 23, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-tech company focused on the research and [...]
Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2020
23/08/2019
DUBLIN, Aug. 23, 2019 (GLOBE NEWSWIRE) -- The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2020 second quarter cash dividend of $0.54 per ordinary share, representing an 8 percent [...]
Ossur Hf : Capital Markets Day on 24 September 2019 in Copenhagen
23/08/2019
Össur invites financial analysts, institutional investors, lenders and financial media to a Capital Markets Day in Copenhagen on 24 September 2019. The Capital Markets Day is hosted by Jon Sigurdsson, President & [...]
Periodic update on transaction details related to Philips’ share repurchases
23/08/2019
August 23, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from August 16, 2019 up to and including August 22, 2019 a total of 267,512 of its own common shares [...]
Oasmia ADSs delisted from NASDAQ in the US
23/08/2019
Oasmia Pharmaceutical AB has previously communicated that the company intends to delist its American Depositary Shares (“ADS”) from the Nasdaq Capital Market (“NASDAQ”) in the US. The delisting is now effective. The [...]
Chi-Med Initiates a Phase I Trial of HMPL-523 in Patients with Immune Thrombocytopenia (ITP) in China
23/08/2019
LONDON, Aug. 23, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase (“Syk”) inhibitor, in patients with [...]
MDxHealth: MDxHealth Notice of Interim Results 2019
23/08/2019
REGULATED INFORMATION Conference call for analysts and investors to be held on 29 August 2019 at 11.00 CEST IRVINE, CA, and HERSTAL, BELGIUM – 07.00 CEST, 23 August 2019 – MDxHealth SA (Euronext: MDXH.BR) or the “ [...]

Pages